EUDA Health Holdings Cash on Hand 2022-2023 | EUDA

EUDA Health Holdings cash on hand from 2022 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
EUDA Health Holdings Annual Cash on Hand
(Millions of US $)
2023 $0
2022 $1
2021 $0
EUDA Health Holdings Quarterly Cash on Hand
(Millions of US $)
2023-03-31 $1
2022-12-31
2022-03-31
2021-12-31 $0
2021-10-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.058B $0.004B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.449B 20.01
Inspire Medical Systems (INSP) United States $4.716B 0.00
Hims & Hers Health (HIMS) United States $3.626B 0.00
Axonics (AXNX) United States $3.429B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.981B 0.00
IRhythm Technologies (IRTC) United States $2.766B 0.00
Enovis (ENOV) United States $2.756B 20.42
Azenta (AZTA) United States $2.746B 154.36
10x Genomics (TXG) United States $2.692B 0.00
Privia Health (PRVA) United States $2.065B 115.40
Schrodinger (SDGR) United States $1.597B 0.00
Omnicell (OMCL) United States $1.498B 51.79
Phreesia (PHR) United States $1.297B 0.00
Standard BioTools (LAB) United States $0.940B 0.00
Definitive Healthcare (DH) United States $0.663B 0.00
Fulgent Genetics (FLGT) United States $0.640B 0.00
Clover Health Investments (CLOV) United States $0.496B 0.00
Talkspace (TALK) United States $0.485B 0.00
Health Catalyst (HCAT) United States $0.397B 0.00
Pulmonx (LUNG) United States $0.313B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.309B 0.00
Butterfly Network (BFLY) United States $0.213B 0.00
Outset Medical (OM) United States $0.200B 0.00
P3 Health Partners (PIII) United States $0.187B 0.00
TruBridge (TBRG) United States $0.151B 8.10
American Well (AMWL) United States $0.128B 0.00
111 (YI) China $0.103B 0.00
MSP Recovery (LIFW) United States $0.098B 0.00
SHL Telemedicine (SHLT) Israel $0.081B 0.00
HeartBeam (BEAT) United States $0.072B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.057B 0.00
Augmedix (AUGX) United States $0.056B 0.00
Zepp Health (ZEPP) China $0.046B 0.00
Movano (MOVE) United States $0.044B 0.00
CareCloud (CCLD) United States $0.041B 0.00
Akili (AKLI) United States $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00